Rule 15c3-4 requires OTC derivatives
dealers to establish and document a risk management control system.
In addition, the Rule establishes basic principles and minimum
standards governing the creation, execution, and review of a firm's
risk management control system. These principles and standards are
designed to ensure the integrity of the risk measurement,
monitoring, and management process.
US Code:
15
USC 78o Name of Law: Securities Exchange Act of 1934
The reduction in burden hours
is due to a decrease in the estimated number of registrants subject
to the rule. The Commission now estimates that a total of six
entities will be registered as OTC derivatives dealers at the end
of the next three years, consisting of the four current OTC
derivatives dealers and two anticipated registrants (in contrast
with the prior estimate of eight OTC derivatives dealers,
consisting of four current OTC derivatives dealers and four
anticipated registrants).
$33,264
No
No
No
No
No
Uncollected
Timothy Fox 202
551-5687
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.